pharma companies working glp 1 GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Market Overview: GLP-1 Agonists and

Join thousands whove discovered the Compounded Tirzepatide for sustainable weight loss for just $37.25/week with your first order of a 12-week supply

Nat Chem Biol 5:749757

As of 2024, researchers estimated that about 12% or one in every eight adult Americans had ever taken a GLP-1 medication

PMID: 22867943

Xie N, Gong H, Suhl JA, Chopra P, Wang T, Warren ST

Research published in Cell shows that treatment of naturally aged mice with FOXO4-DRI significantly improved physical performance, with treated animals running approximately double the distance on voluntary running wheels compared to untreated age-matched counterparts